MilliporeSigma Launches Neutral Lipid Ahead of Schedule to Meet COVID-19 Demand

MilliporeSigma has launched SAFC, a high-purity synthetic cholesterol product, nine months ahead of schedule to meet the lipid demands for COVID-19 messenger RNA therapeutics.